Loading...
XNAS
LEDS
Market cap18mUSD
Oct 08, Last price  
2.29USD
1D
-5.37%
1Q
40.49%
Jan 2017
-34.76%
IPO
-99.11%
Name

SemiLEDs Corp

Chart & performance

D1W1MN
XNAS:LEDS chart
P/E
—
P/S
0.44
EPS
—
Div yield, %
—
Shrs. gr., 5y
14.51%
Rev. gr., 5y
47.95%
Revenues
43m
+729.81%
6,860,00014,749,00011,551,00035,763,00033,902,00029,299,00017,967,00014,481,00014,124,00010,140,0009,214,0007,495,0005,902,0006,068,0004,735,0007,051,0005,979,0005,183,00043,009,000
Net income
-1m
L-44.50%
101,000-814,000-3,693,00010,828,000-16,104,000-49,457,000-43,724,000-24,475,000-13,274,000-21,275,000-4,091,000-2,981,000-3,565,000-544,000-2,851,000-2,744,000-2,690,000-2,036,000-1,130,000
CFO
2m
P
-3,025,0002,399,000-454,0008,537,000-2,050,000-15,771,000-14,461,000-15,698,000-4,525,000-3,439,000-2,109,000-1,177,000-3,546,000-1,000,999-1,737,000-1,508,000-984,000-365,0002,212,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

SemiLEDs Corporation develops, manufactures, and sells light emitting diode (LED) chips, components, and modules and systems in the United States, Taiwan, the Netherlands, Japan, and internationally. The company also sells enhanced vertical, LED product series in blue, white, green, and UV; LED chips to packagers or distributors; and lighting products primarily to original design manufacturers of lighting products and the end-users of lighting devices, as well as packs and sells its LED products. Its products are used for general lighting applications, including commercial, industrial, and residential lighting; LED luminaries and LED retrofits; and specialty industrial applications, including ultraviolet curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, germicidal and viricidal devices, LED lighting for horticulture applications, architectural lighting, and entertainment lighting. SemiLEDs Corporation was incorporated in 2005 and is based in Chu-Nan, Taiwan.

Key people

Trung T. Doan
Chairman of the Board, President, Chief Executive Officer · since 2012
Christopher Lee
Chief Financial Officer, Director · since 2019
Walter Michael Gough
Independent Director · since 2016
Kuan Hsiung Hsieh
Independent Director · since 2012
Scott R. Simplot
Independent Director · since 2005
IPO date
Dec 08, 2010
Employees
126
Domiciled in
TW
Incorporated in
US
Legal address
c/o Cogency Global Inc., 850 New Burton Road, Suite 201
Dover, DE 19904
US
Headquarters
3F, No. 11 Ke Jung Road, Chu-Nan Site, Hsinchu Science Park
Chu-Nan, MIA F5 350
TW

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2025‑082024‑082023‑082022‑082021‑082020‑082019‑082018‑082017‑08
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT